ACRIVON THERAPEUTICS INC (ACRV) Stock Income Statement
NASDAQ:ACRV • US0048901096
Current stock price
1.33 USD
-0.09 (-6.34%)
At close:
1.32 USD
-0.01 (-0.75%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 84.11M | 89.20M | 67.10M | 32.66M | 16.18M | |||
| Research and Development | 59.99M | 63.99M | 46.02M | 23.95M | 13.72M | |||
| Selling, General, and Administrative Expenses | 24.12M | 25.21M | 21.08M | 8.71M | 2.47M | |||
| Operating Income | -84.11M | -89.20M | -67.10M | -32.66M | -16.18M | |||
| Interest Income/Expense | 6.48M | 9.20M | N/A | N/A | 0.00 | |||
| Other Income/Expense | -270.00K | -558.00K | 6.71M | 1.49M | -160.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 100.00K | |||
| Income Before Taxes | -77.91M | -80.56M | -60.39M | -31.17M | -16.24M | |||
| Net Income | -77.91M | -80.56M | -60.39M | -31.17M | -16.24M | |||
| EBITDA | -82.76M | -88.19M | -66.57M | -32.30M | -16.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.02 | -2.38 | -2.74 | -1.42 | -0.78 | |||
| Non GAAP EPS | -2.05 | -2.44 | -2.73 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD